Matsumori, A <br/><br/>
Differential modulation of cytokine production by drugs: implications for therapy in heart failure.  [electronic resource] 

 -  Journal of molecular and cellular cardiology  Dec 1996 
 - 2491-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-2828 
<br/><br/><label>Standard No.: </label>10.1006/jmcc.1996.0241  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-AMP Phosphodiesterases--antagonists & inhibitors<br/>3',5'-Cyclic-GMP Phosphodiesterases<br/>4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone--pharmacology<br/>8-Bromo Cyclic Adenosine Monophosphate--pharmacology<br/>Amrinone--pharmacology<br/>Cells, Cultured<br/>Cyclic GMP--analogs & derivatives<br/>Cyclic Nucleotide Phosphodiesterases, Type 3<br/>Cyclic Nucleotide Phosphodiesterases, Type 4<br/>Cyclic Nucleotide Phosphodiesterases, Type 5<br/>Heart Failure--therapy<br/>Humans<br/>Interleukin-1--biosynthesis<br/>Interleukin-6--biosynthesis<br/>Kinetics<br/>Leukocytes, Mononuclear--cytology<br/>Lipopolysaccharides--pharmacology<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Phosphoric Diester Hydrolases<br/>Piperidines--pharmacology<br/>Pyrazines<br/>Pyridazines--pharmacology<br/>Quinazolines--pharmacology<br/>Quinolines--pharmacology<br/>Tumor Necrosis Factor-alpha--biosynthesis